JUSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Jushi Holdings Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026

$0.49−0.03 (-5.50%)

Close on Oct 19, 2026

Market cap: $98.11M
P/E (TTM): –
Dividend yield: –

Jushi Holdings Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31
Revenue	263	258	269	284	209	81
Cost of Revenue	149	139	153	189	126	42
Gross Profit	114	118	116	95	83	38
Selling, General & Admin	109	107	110	156	113	55
Operating Expenses	109	107	119	316	119	55
Operating Income	4.85	11	-2.82	-220	-36	-17
Interest Expense	41	38	37	46	31	16
Interest & Investment Income	0.46	0.56	0.09	0.14	0.24	0.23
Other Non-Operating Income	-38	-28	-30	26	83	-185
Asset Impairment Charges	0	0.43	8.57	160	6.34	0
Gain (Loss) on Investments	0	-0.20	-0.78	-0.52	1.22	-2.47
Gain (Loss) on Sale of Assets	2.40	0.73	1.65	–	–	–
Legal Settlements	0.71	0.40	-0.40	0.02	10	-2.22
Income Tax Expense	35	32	32	8.45	30	11
Net Income incl. Noncontrolling Interests	-69	-49	-65	-202	17	-213
Minority Interest in Earnings	–	–	0	0	-2.77	-1.91
Net Income	-69	-49	-65	-202	20	-211
Net Income to Common	–	–	-65	-294	-84	-211
EPS (Basic)(per share)	-0.35	-0.25	-0.33	-1.06	0.12	-1.94
EPS (Diluted)(per share)	-0.35	-0.25	-0.33	-1.44	-0.42	-1.94
Shares Outstanding (Basic, Weighted)(shares)	195	195	195	190	170	108
Shares Outstanding (Diluted, Weighted)(shares)	195	195	195	204	202	108
EBITDA	36	41	24	-194	-27	-12
Net Interest Income	–	–	-37	-46	-31	-15

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 44.4%
Operating margin: 2.0%
Net margin: -25.2%
Return on equity, FY2025: 82.8%

Financial strength

Current ratio: 0.83
Debt to equity: -1.62
Debt to assets: 53.5%
Cash to current liabilities: 35.8%

Valuation

P/E ratio: –
Price to sales: 0.36
Price to book: –
Dividend yield: –